MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Начало・Списък с акции・Pfizer

Pfizer

Затворен

СекторЗдравеопазване

24.31 -1.58

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

24.31

Максимум

24.86

Ключови измерители
By Trading Economics
Приходи	-4.1B 411M
Продажби	63M 18B
P/E Средно за сектора	17.972 63.778
EPS	0.63
Дивидентна доходност	6.79
Марж на печалбата	2.314
Служители	81,000
EBITDA	-4.3B 2.5B

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+23.81% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	6.79% 2.39%
Следващи печалби	29.04.2025 г.
Следваща дата на дивидент	13.06.2025 г.
Следваща дата на екс-дивидент	8.05.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-7.5B 144B
Предишно отваряне	25.89
Предишно затваряне	24.31

Настроения в новините

By Acuity

45%

55%

165 / 386 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

24.52 / 25.23 Подкрепа & съпротива

Pfizer Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

19.03.2025 г., 07:34 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

18.03.2025 г., 17:26 ч. UTC

Придобивния, сливания и поглъщания

Pfizer to Dispose of Remaining Shareholding in Haleon

4.02.2025 г., 18:52 ч. UTC

Значими двигатели на пазара

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

4.02.2025 г., 14:58 ч. UTC

Печалби

Значими двигатели на пазара

Pfizer Shares Rise on Better-Than-Expected 4Q

26.03.2025 г., 22:29 ч. UTC

Топ новини

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- 2nd Update

26.03.2025 г., 19:19 ч. UTC

Топ новини

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- Update

26.03.2025 г., 17:39 ч. UTC

Топ новини

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- WSJ

18.03.2025 г., 16:58 ч. UTC

Придобивния, сливания и поглъщания

Haleon Intends to Cancel Purchased Ordinary Shares

18.03.2025 г., 16:57 ч. UTC

Придобивния, сливания и поглъщания

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

18.03.2025 г., 16:56 ч. UTC

Придобивния, сливания и поглъщания

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

18.03.2025 г., 16:56 ч. UTC

Придобивния, сливания и поглъщания

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

18.03.2025 г., 16:52 ч. UTC

Придобивния, сливания и поглъщания

Haleon Takes Note of Announcement

18.03.2025 г., 16:50 ч. UTC

Придобивния, сливания и поглъщания

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

18.03.2025 г., 16:50 ч. UTC

Придобивния, сливания и поглъщания

Citigroup: This Is Subject to Customary Closing Conditions

18.03.2025 г., 16:50 ч. UTC

Придобивния, сливания и поглъщания

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

18.03.2025 г., 16:49 ч. UTC

Придобивния, сливания и поглъщания

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

18.03.2025 г., 16:49 ч. UTC

Придобивния, сливания и поглъщания

Citigroup: Bookbuilding Period Will Commence Immediately

18.03.2025 г., 16:49 ч. UTC

Придобивния, сливания и поглъщания

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

18.03.2025 г., 16:48 ч. UTC

Придобивния, сливания и поглъщания

Citigroup: Pfizer Intends to Sell Ordinary Shares to Institutional Investors

18.03.2025 г., 16:47 ч. UTC

Придобивния, сливания и поглъщания

Citigroup:: Amount Is Pfizer's Entire Residual Shareholding in Haleon

18.03.2025 г., 16:47 ч. UTC

Придобивния, сливания и поглъщания

Citigroup: This Represents Approx 7.3% Stake in Haleon

18.03.2025 г., 16:46 ч. UTC

Придобивния, сливания и поглъщания

Citigroup: Pfizer Intends to Sell Approx 662M Ordinary Shares in Haleon

17.03.2025 г., 09:00 ч. UTC

Топ новини

Pfizer Has a New Playbook for Reviving Sales -- And It's Starting to Pay Off -- WSJ

28.02.2025 г., 12:00 ч. UTC

Топ новини

Drug Stocks Are the New Safe Bet in a Shaky Market -- Heard on the Street -- WSJ

14.02.2025 г., 11:38 ч. UTC

Топ новини

Печалби

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

14.02.2025 г., 11:30 ч. UTC

Топ новини

Печалби

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

5.02.2025 г., 12:00 ч. UTC

Топ новини

Merck Is Suffering From a Classic Pharma Problem -- Heard on the Street -- WSJ

4.02.2025 г., 19:34 ч. UTC

Топ новини

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 3rd Update

4.02.2025 г., 19:10 ч. UTC

Топ новини

Pfizer Falls on RFK's Progress Towards Confirmation Despite Good Earnings. Its CEO is Unbothered. -- Barrons.com

4.02.2025 г., 18:51 ч. UTC

Топ новини

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 2nd Update

Сравнение с други в отрасъла

Ценова промяна

Pfizer Прогноза

Ценова цел

By TipRanks

23.81% нагоре

12-месечна прогноза

Среден 30.58 USD 23.81%

Висок 36 USD

Нисък 27 USD

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за Pfizer през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

15 ratings

Купи

Задържане

Продай

Според 15 анализатори, дали борсови рейтинги на Pfizer през последните 3 месеца.

Техническа оценка

By Trading Central

24.52 / 25.23Подкрепа & съпротива

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Настроение

By Acuity

165 / 386 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.